Reinforcing and discriminative stimulus effects of 1-benzylpiperazine and trifluoromethylphenylpiperazine in rhesus monkeys

Drug and Alcohol Dependence

Volumn 77, Issue 2, 2005, Pages 161-168

  Fantegrossi, W E ^a   Winger, G ^a   Woods, J H ^a   Woolverton, W L ^b   Coop, A ^c  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

Author keywords

Drug discrimination; Piperazines; Rhesus monkeys; Self administration

Indexed keywords

1 (3 TRIFLUOROMETHYLPHENYL)PIPERAZINE; 1 BENZYLPIPERAZINE DERIVATIVE; AMPHETAMINE; COCAINE; PIPERAZINE DERIVATIVE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; DOSE RESPONSE; DRUG ABUSE; DRUG SELF ADMINISTRATION; FEMALE; MALE; NONHUMAN; PRIORITY JOURNAL; RHESUS MONKEY; STIMULUS;

ANIMALS; DISCRIMINATION LEARNING; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; MACACA MULATTA; MALE; PIPERAZINES; REINFORCEMENT SCHEDULE; SELF ADMINISTRATION;

MACACA MULATTA; PRIMATES;

EID: 12344255162     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2004.07.014     Document Type: Article

References (39)

1. S.B. Auerbach, N. Kamalakannan, and J.J. Rutter TFMPP and RU24969 enhance serotonin release from rat hippocampus Eur. J. Pharmacol. 190 1990 51 57
2. S.B. Auerbach, J.J. Rutter, and P.J. Juliano Substituted piperazine and indole compounds increase extracellular serotonin in rat diencephalon as determined by in vivo microdialysis Neuropharmacology 304 1991 307 311
3. K.A. Berg, S. Maayani, J. Goldfarb, C. Scaramellini, P. Leff, and W.P. Clarke Effector pathway-dependent relative efficacy at serotonin type 2A and 2C receptors: evidence for agonist-directed trafficking of receptor stimulus Mol. Pharmacol. 54 1998 94 104
4. Berger, M., 2003. Trifluoromethylphenylpiperazine (TFMPP): an entheogenic entactogen. Erowid.org, http://www.erowid.org/chemicals/tfmpp/tfmpp_article1. shtml, accessed 19 May 2004.
5. J.B. Brown Schedules of controlled substances: temporary placement of benzylpiperazine and trifluoromethylphenylpiperazine into Schedule I Federal Register 67 2002 59161 59162
6. C. Bye, A.D. Munro-Faure, A.W. Peck, and P.A. Young A comparison of the effects of 1-benzylpiperazine and dexamphetamine on human performance tests Eur. J. Clin. Pharmacol. 6 1973 163 169
7. H. Campbell, W. Cline, M. Evans, J. Lloyd, and A.W. Peck Comparison of the effects of dexamphetamine and 1-benzylpiperazine in former addicts Eur. J. Clin. Pharmacol. 6 1973 170 176
8. P.J. Conn, and E. Sanders-Bush Relative efficacies of piperazines at the phosphoinositide hydrolysis-linked serotonergic (5-HT-2 and 5-HT-1c) receptors J. Pharmacol. Exp. Ther. 242 1987 552 557
9. K.A. Cunningham, and J.B. Appel Possible 5-hydroxytrptamine (5-HT1) receptor involvement in the stimulus properties of 1-(m-trifluoromethylphenyl) piperazine (TFMPP) J. Pharmacol. Exp. Ther. 237 1986 369 377
10. P.W. Czoty, B.C. Ginsburg, and L.L. Howell Serotonergic attenuation of the reinforcing and neurochemical effects of cocaine in squirrel monkeys J. Pharmacol. Exp. Ther. 300 2002 831 837
11. D. de Boer, I.J. Bosman, E. Hidvégi, C. Manzoni, A.A. Benkö, L.J.A.L. dos Reys, and R.A.A. Maes Piperazine-like compounds: a new group of designer drugs-of-abuse on the European market Forensic Sci. Int. 121 2001 47 56
12. 2C receptors Brain Res. 865 2000 85 90
13. 2C receptors in the control of central dopamine function Trends Pharmacol. Sci. 22 2001 229 232
14. W.E. Fantegrossi, J.H. Woods, G. Winger, L.R. McMahon, C.P. France, W.L. Woolverton, J.C. Winter, and K.A. Cunningham Progress report from the testing program for stimulant and depressant drugs W.L. Dewey Problems of Drug Dependence, 2003: Proceedings of the 65th Annual Scientific Meeting The College on Problems of Drug Dependence, Inc. (National Institute on Drug Abuse Research Monograph #184, 205-231) 2003 U.S. Government Printing Office Washington, DC
15. M.I.K. Fekete, T. Szentendrei, J.P. Hermán, and B. Kanyicska Effects of reserpine and antidepressants on dopamine and DOPAC (3,4-dihydroxyphenylacetic acid) concentrations in the striatum olfactory tubercle and median eminence of rats Eur. J. Pharmacol. 64 1980 231 238
16. R.A. Glennon, R.M. Slusher, R.A. Lyon, M. Titeler, and J.D. McKenney 5-HT1 and 5-HT2 binding characteristics of some quipazine analogues J. Med. Chem. 29 11 1986 2375 2380
17. R.A. Glennon, M.E. Pierson, and J.D. McKenney Stimulus generalization of 1-(3-trifluoromethylphenyl)piperazine (TFMPP) to propranolol, pindolol, and mesulergine Pharmacol. Biochem. Beh. 29 1988 197 199
18. 2A receptors expressed in fibroblasts J. Pharmacol. Exp. Ther. 271 1994 1122 1126
19. J.L. Herndon, M.E. Pierson, and R.A. Glennon Mechanistic investigation of the stimulus properties of 1-(3-trifluoromethylphenyl)piperazine Pharmacol. Biochem. Beh. 43 1992 739 748
20. L.L. Howell, and L.D. Byrd Serotonergic modulation of the behavioral effects of cocaine in the squirrel monkey J. Pharmacol. Exp. Ther. 275 1995 1551 1559
21. C.N. Jones, J.L. Howard, and S.T. McBennett Stimulus properties of antidepressants in the rat Psychopharmacology 67 1980 111 118
22. M.S. Kleven, and W.L. Woolverton Effects of three monoamine uptake inhibitors on behavior maintained by cocaine or food presentation in rhesus monkeys Drug Alcohol Depend. 31 1993 149 158
23. I. Kosóczky, K. Grasser, E. Kiszelly, E. Toncsev, and L. Petöcz The antidepressant activity of a new piridincarbonic acid derivative, EGYT-475 Proceedings of the Seventh International Congress of Pharmacology Abstract No. 486 1978 Pergamon Press Paris
24. K. Magyar Pharmacokinetic aspects of the mode of action of EGYT-475, a new antidepressive agent K. Magyar T. Szüts L. Vereczkey Proceedings of the Symposium of Pharmacokinetics and Drug Metabolism 1988 Akadémiai Kiadó-Pergamon Press Budapest, Oxford 152 164
25. 1B receptors? J. Neural Transmission 73 1988 43 55
26. B. Malomvölgyi, L. Tóthfalusi, K. Tekes, and K. Magyar Comparison of serotonin agonistic and antagonistic activities of a new antidepressant agent trelibet (EGYT-475) and its metabolite EGYT-2760 on isolated rat fundus Acta Physiol. Hungarica 78 1991 201 209
27. Miller, A.A., Green, A.F., Young, P.A., 1971. Unpublished work, as cited by Bye et al. (1973).
28. C. Oberlander, C. Euvrard, C. Dumont, and J.R. Boissier Circling behavior induced by dopamine releasers and/or uptake inhibitors during degeneration of the nigrostriatal pathway Eur. J. Pharmacol. 60 1979 163 170
29. A. Poling, and J. Bryceland Voluntary drug self-administration by nonhumans: a review J. Psychedelic Drugs 11 1979 185 190
30. S. Prisco, S. Pagannone, and E. Esposito Serotonin-dopamine interaction in the rat ventral tegmental area: an electrophysiological study in vivo J. Pharmacol. Exp. Ther. 271 1994 83 90
31. N.R. Richardson, and D.C.S. Roberts Fluoxetine pretreatment reduces breaking points on a progressive ratio schedule reinforced by intravenous cocaine self-administration in the rat Life Sci. 49 1991 833 840
32. G. Rudnick, and S. Wall The molecular mechanism of [3,4-methylenedioxy- methamphetamine (MDMA)]: serotonin transporters are targets for MDMA-induced serotonin release Proc. Nat. Acad. Sci. USA 89 1992 1817 1821
33. B. Sadzot, J.M. Baraban, R.A. Glennon, and R.A. Lyon Hallucinogenic drug interactions at human brain 5-HT2 receptors: Implications for treating LSD-induced hallucinogenesis Psychopharmacology 98 4 1989 495 499
34. 1B receptor activation Pharmacol. Biochem. Beh. 31 1988 53 57
35. M.D. Schechter Serotonergic-dopaminergic mediation of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") Pharmacol. Biochem. Beh. 31 1988 817 824
36. 1B receptor ligands exist? Naunyn-Schmiedebergs Arch. Pharmacol. 339 1989 675 683
37. K. Tekes, T. László, B. Malomvölgyi, F. Hermán, and K. Magyar Studies on the biochemical mode of action of EGYT-475, a new antidepressant Pol. J. Pharmacol. Pharm. 39 1987 203 211
38. United States Department of Justice/Drug Enforcement Administration, 2003. System to Retrieve Information from Drug Evidence II (STRIDE).
39. W.L. Woolverton, and J.A. English Effects of some phenylethylamines in rhesus monkeys trained to discriminate (+)-amphetamine from saline Drug. Alc. Dep. 44 1997 79 85